A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.

Inclusion Criteria: * Capable of giving informed consent * Agrees to use effective contraception * Body Mass Index (BMI) between 18.0 and 32.0 kg/m2 * Healthy by medical evaluation and medical history * Hematological parameters, serum iron, transferrin and ferritin are within normal range and transferrin saturation is within normal range and greater than or equal to 20% * Can swallow tablets and has suitable venous access for blood sampling Exclusion Criteria: * Has dietary requirements that may be difficult to accommodate * Is a regular user of cannabis or has a history of illicit drug abuse within 1 year * Has a history of alcohol abuse or binge drinking within 6 months * Is a regular user of tobacco or nicotine-containing products * Unwilling or unable to comply with the lifestyle guidelines described in the protocol * Has clinically significant history or evidence of cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, neurological, immunological, or psychiatric disorder(s) as determined by the Investigator * Has any concurrent disease or condition or physical, psychological, mental, and/or social reason that, in the opinion of the Investigator, would make the participant unsuitable for participation in the clinical study * Has received a blood transfusion within 1 year * Has donated whole blood within 6 months or plasma within 30 days * Requires prescription medication or regular use of non-prescription medication * Is an employee of the Sponsor, the CRO, or of any organization or site(s) associated with this study, or any immediate family member who is in a dependent relationship with a study site employee who is involved in the conduct of the study